Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PANACEA LIFE SCIENCES HOLDINGS, INC.EXDI · Entity 9699 | CONTROLLER & PRIN ACTNG OFCR | June 30, 2021 | July 12, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PANACEA LIFE SCIENCES HOLDINGS, INC.
Report date June 30, 2021 · Filed July 12, 2021
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2021 Filed Jul 6, 2021 21:28 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantStock Options (Right to Buy) · Derivative | 496,957 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001415889-21-003515 · form4-07062021_020722.xml · derivative · entry 2 Berman Nathan Joel · CIK 0001871296 · CONTROLLER & PRIN ACTNG OFCR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,957 Underlying: Common Stock · 496,957 shares Expires 2026-06-30 F2 · derivative.exercise_date: One-half of the stock options vest upon the effective date of a 1:28 reverse stock split of the Issuer's common stock, and the remainder vest on June 30, 2022, subject to continued employment with the Issuer. Read SEC document |
| June 30, 2021 Filed Jul 6, 2021 21:28 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantCommon Stock | 496,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003515 · form4-07062021_020722.xml · nonDerivative · entry 1 Berman Nathan Joel · CIK 0001871296 · CONTROLLER & PRIN ACTNG OFCR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,957 F1 · price: The shares of common stock of the Issuer were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. ("Panacea"), in connection with the Securities Exchange Agreement dated June 30, 2021 by and among the Issuer, Panacea and the shareholders of Panacea. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.